These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7614999)

  • 1. Expression of Epstein-Barr virus nuclear antigen-2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21.
    Larcher C; Kempkes B; Kremmer E; Prodinger WM; Pawlita M; Bornkamm GW; Dierich MP
    Eur J Immunol; 1995 Jun; 25(6):1713-9. PubMed ID: 7614999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1.
    Peng M; Lundgren E
    Leukemia; 1993 Jan; 7(1):104-12. PubMed ID: 8093369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
    Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM
    J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
    Peng M; Lundgren E
    Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23.
    Frémeaux-Bacchi V; Bernard I; Maillet F; Mani JC; Fontaine M; Bonnefoy JY; Kazatchkine MD; Fischer E
    Eur J Immunol; 1996 Jul; 26(7):1497-503. PubMed ID: 8766552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T lymphotropic virus-type I Tax induction of CD21/Epstein-Barr virus receptor expression on T cells and its significance in leukemogenesis of adult T cell leukemia.
    Ohtsubo H; Arima N; Matsushita K; Hidaka S; Fujiwara H; Arimura K; Kukita T; Fukumori J; Matsumoto T; Eizuru Y; Tanaka H
    Exp Hematol; 1997 Nov; 25(12):1246-52. PubMed ID: 9357968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus nuclear antigen 2-estrogen receptor fusion proteins transactivate viral and cellular genes and interact with RBP-J kappa in a conditional fashion.
    Kempkes B; Pawlita M; Zimber-Strobl U; Eissner G; Laux G; Bornkamm GW
    Virology; 1995 Dec; 214(2):675-9. PubMed ID: 8553575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis.
    Masilamani M; von Kempis J; Illges H
    Rheumatology (Oxford); 2004 Feb; 43(2):186-90. PubMed ID: 12867574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context.
    Cordier-Bussat M; Billaud M; Calender A; Lenoir GM
    Int J Cancer; 1993 Jan; 53(1):153-60. PubMed ID: 8416201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD23/CD21 interaction is required for presentation of soluble protein antigen by lymphoblastoid B cell lines to specific CD4+ T cell clones.
    Grosjean I; Lachaux A; Bella C; Aubry JP; Bonnefoy JY; Kaiserlian D
    Eur J Immunol; 1994 Dec; 24(12):2982-6. PubMed ID: 7805725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human thymocytes after infection by EBV.
    Paterson RL; Kelleher CA; Streib JE; Amankonah TD; Xu JW; Jones JF; Gelfand EW
    J Immunol; 1995 Feb; 154(3):1440-9. PubMed ID: 7822809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epstein-Barr virus nuclear antigen 2 (EBNA2), a protein required for B lymphocyte immortalization, induces the synthesis of type I interferon in Burkitt's lymphoma cell lines.
    Kanda K; Kempkes B; Bornkamm GW; von Gabain A; Decker T
    Biol Chem; 1999 Feb; 380(2):213-21. PubMed ID: 10195428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines.
    Floettmann JE; Ward K; Rickinson AB; Rowe M
    Virology; 1996 Sep; 223(1):29-40. PubMed ID: 8806537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of human IgE production by a subset of anti-CD21 monoclonal antibodies: requirement of a co-signal to modulate epsilon transcripts.
    Henchoz S; Gauchat JF; Aubry JP; Graber P; Pochon S; Bonnefoy JY
    Immunology; 1994 Feb; 81(2):285-90. PubMed ID: 7512529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV) infection in B-cell non-Hodgkin's lymphomas in children: virus latency and its correlation with CD21 and CD23 molecules.
    Kasprzak A; Spachacz R; Wachowiak J; Stefanska K; Zabel M
    Folia Histochem Cytobiol; 2007; 45(3):169-79. PubMed ID: 17951165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligation of the functional domain of complement receptor type 2 (CR2, CD21) is relevant for complex formation in T cell lines.
    Prodinger WM; Larcher C; Schwendinger M; Dierich MP
    J Immunol; 1996 Apr; 156(7):2580-4. PubMed ID: 8786322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell activation leads to shedding of complement receptor type II (CR2/CD21).
    Masilamani M; Kassahn D; Mikkat S; Glocker MO; Illges H
    Eur J Immunol; 2003 Sep; 33(9):2391-7. PubMed ID: 12938215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines.
    Kempkes B; Zimber-Strobl U; Eissner G; Pawlita M; Falk M; Hammerschmidt W; Bornkamm GW
    J Gen Virol; 1996 Feb; 77 ( Pt 2 )():227-37. PubMed ID: 8627226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-barr virus nuclear antigen 2 retards cell growth, induces p21(WAF1) expression, and modulates p53 activity post-translationally.
    Lin CS; Kuo HH; Chen JY; Yang CS; Wang WB
    J Mol Biol; 2000 Oct; 303(1):7-23. PubMed ID: 11021966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
    Jochner N; Eick D; Zimber-Strobl U; Pawlita M; Bornkamm GW; Kempkes B
    EMBO J; 1996 Jan; 15(2):375-82. PubMed ID: 8617212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.